Evaluation of the anti-tumor and anti-angiogenic effect of paclitaxel and thalidomide on the xenotransplanted oral squamous cell carcinoma (Q31880216)

4 July 2017

title

Evaluation of the anti-tumor and anti-angiogenic effect of paclitaxel and thalidomide on the xenotransplanted oral squamous cell carcinoma (English)

1 reference

4 July 2017

0 references

angiogenesis inhibitor

1 reference

oral squamous cell carcinoma

inferred from title

1 reference

1 reference

Myoung H

1

1 reference

4 July 2017

Hong SD

2

1 reference

4 July 2017

Kim YY

3

1 reference

4 July 2017

Hong SP

4

1 reference

4 July 2017

Kim MJ

5

1 reference

4 July 2017

language of work or name

English

0 references

publication date

1 February 2001

1 reference

4 July 2017

1 reference

4 July 2017

volume

163

1 reference

4 July 2017

issue

2

1 reference

4 July 2017

page(s)

191-200

1 reference

What Is the Evidence That Tumors Are Angiogenesis Dependent?

4 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900701-1

7 January 2021

Clinical research on antiangiogenic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900701-1

7 January 2021

Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900701-1

7 January 2021

Relation of neovascularisation to metastasis of non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900701-1

7 January 2021

Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900701-1

7 January 2021

Designing therapies that target tumor blood vessels

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900701-1

7 January 2021

Vitaxin, a humanized monoclonal antibody to the vitronectin receptor (alphavbeta3), reduces neointimal hyperplasia and total vessel area after balloon injury in hypercholesterolemic rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900701-1

7 January 2021

Thalidomide is an inhibitor of angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900701-1

7 January 2021

Effects of thalidomide and related metabolites in a mouse corneal model of neovascularization

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900701-1

7 January 2021

Thalidomide inhibits corneal angiogenesis induced by vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900701-1

7 January 2021

Combination oral antiangiogenic therapy with thalidomide and sulindac inhibits tumour growth in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900701-1

7 January 2021

Taxol: a unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900701-1

7 January 2021

Controlled delivery of taxol from microspheres composed of a blend of ethylene-vinyl acetate copolymer and poly (d,l-lactic acid).

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900701-1

7 January 2021

Taxol encapsulation in poly(epsilon-caprolactone) microspheres

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900701-1

7 January 2021

Molecular mechanisms of blood vessel formation

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900701-1

7 January 2021

Immunohistochemical study of tumour angiogenesis in oral squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900701-1

7 January 2021

Endothelial receptor tyrosine kinases involved in angiogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900701-1

7 January 2021

Mechanisms of angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900701-1

7 January 2021

Regulation of animal care and research? NIH's opinion

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900701-1

7 January 2021

Leukocyte-induced angiogenesis and subcutaneous growth of B16 melanoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900701-1

7 January 2021

JC70: a new monoclonal antibody that detects vascular endothelium associated antigen on routinely processed tissue sections

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900701-1

7 January 2021

Angiogenesis in ductal breast carcinoma. Comparison of microvessel density between primary tumour and lymph node metastasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900701-1

7 January 2021

Angiogenesis in vulvar intraepithelial neoplasia.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900701-1

7 January 2021

Influence of microvessel density and vascular permeability factor/vascular endothelial growth factor expression on prognosis in vulvar cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900701-1

7 January 2021

Effects of an anti-angiogenic agent, TNP-470, on the growth of oral squamous cell carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900701-1

7 January 2021

Effect of thalidomide on tumour necrosis factor production and anti-tumour activity induced by 5,6-dimethylxanthenone-4-acetic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900701-1

7 January 2021

Thalidomide promotes metastasis of prostate adenocarcinoma cells (PA-III) in L-W rats

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900701-1

7 January 2021

The effect of thalidomide on experimental tumors and metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900701-1

7 January 2021

Continuous low dose Thalidomide: a phase II study in advanced melanoma, renal cell, ovarian and breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900701-1

7 January 2021

Angiogenesis in the pathobiology and treatment of vascular and malignant diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900701-1

7 January 2021

Tumor angiogenesis in T1 oral cavity squamous cell carcinoma: role in predicting tumor aggressiveness

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900701-1

7 January 2021

10.1016/S0304-3835(00)00701-1

Identifiers

DOI

1 reference

4 July 2017

1 reference